Genedx Holdings [WGS] vs Thermo Fisher [TMO] Detailed Stock Comparison

Genedx Holdings Corp

NASDAQ
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Genedx Holdings Corp wins in 2 metrics, Thermo Fisher Scientific Inc. wins in 16 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Genedx Holdings Corp Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) 724.64 25.84 Thermo Fisher Scientific Inc.
Price-to-Book Ratio 6.63 3.31 Thermo Fisher Scientific Inc.
Debt-to-Equity Ratio 36.72 82.91 Genedx Holdings Corp
PEG Ratio 33.95 2.29 Thermo Fisher Scientific Inc.
EV/EBITDA 157.06 19.02 Thermo Fisher Scientific Inc.
Profit Margin (TTM) -4.92% 15.15% Thermo Fisher Scientific Inc.
Operating Margin (TTM) -10.60% 17.89% Thermo Fisher Scientific Inc.
EBITDA Margin (TTM) N/A 17.89% N/A
Return on Equity -7.60% 13.52% Thermo Fisher Scientific Inc.
Return on Assets (TTM) -1.55% 5.00% Thermo Fisher Scientific Inc.
Free Cash Flow (TTM) $14.26M $6.29B Thermo Fisher Scientific Inc.
Dividend Yield N/A 0.38% N/A
1-Year Return -7.20% 16.53% Thermo Fisher Scientific Inc.
Price-to-Sales Ratio (TTM) 4.78 3.86 Thermo Fisher Scientific Inc.
Enterprise Value $1.99B $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 4.65 4.75 Genedx Holdings Corp
Gross Profit Margin (TTM) 69.65% N/A N/A
Revenue per Share (TTM) $15 $120 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $-0.73 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 2.19 0.97 Thermo Fisher Scientific Inc.
Short % of Float 26.48% 1.22% Thermo Fisher Scientific Inc.

Genedx Holdings Corp vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

WGS
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Genedx Holdings Corp2.34%18.38%50.48%-19.43%-59.29%-53.65%
Thermo Fisher Scientific Inc.0.93%0.87%8.07%0.79%-17.74%-20.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Genedx Holdings Corp-7.20%793.00%332.95%511.43%511.43%511.43%
Thermo Fisher Scientific Inc.16.53%-12.65%-2.72%220.94%654.32%1,231.84%

Performance & Financial Health Analysis: Genedx Holdings Corp vs Thermo Fisher Scientific Inc.

MetricWGSTMO
Market Information
Market Cap i$1.94B$174.55B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i640,4302,356,220
90 Day Avg. Volume i688,1772,071,517
Last Close$61.32$473.72
52 Week Range$32.21 - $170.87$385.46 - $643.99
% from 52W High-64.11%-26.44%
All-Time High$417.42 (Aug 09, 2021)$672.34 (Dec 27, 2021)
% from All-Time High-85.31%-29.54%
Growth Metrics
Quarterly Revenue Growth0.27%0.06%
Quarterly Earnings Growth0.27%0.10%
Financial Health
Profit Margin (TTM) i-0.05%0.15%
Operating Margin (TTM) i-0.11%0.18%
Return on Equity (TTM) i-0.08%0.14%
Debt to Equity (MRQ) i36.7282.91
Cash & Liquidity
Book Value per Share (MRQ)$10.54$141.96
Cash per Share (MRQ)$5.85$8.75
Operating Cash Flow (TTM) i$33.28M$8.29B
Levered Free Cash Flow (TTM) i$38.06M$5.51B
Dividends
Last 12-Month Dividend Yield iN/A0.38%
Last 12-Month Dividend iN/A$1.76

Valuation & Enterprise Metrics Analysis: Genedx Holdings Corp vs Thermo Fisher Scientific Inc.

MetricWGS (Apr 24, 2026)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i724.6425.84
Forward P/E i33.9517.16
PEG Ratio i33.952.29
Price to Sales (TTM) i4.783.86
Price to Book (MRQ) i6.633.31
Market Capitalization
Market Capitalization i$1.94B$174.55B
Enterprise Value i$1.99B$214.76B
Enterprise Value Metrics
Enterprise to Revenue i4.654.75
Enterprise to EBITDA i157.0619.02
Risk & Other Metrics
Beta i2.190.97
Book Value per Share (MRQ) i$10.54$141.96

Financial Statements Comparison: Genedx Holdings Corp vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricWGS (2025)TMO (2025)
Revenue/Sales i427.54M44.56B
Cost of Goods Sold i129.37M26.32B
COGS % of Revenue i30.3%59.1%
Gross Profit i298.17M18.24B
Gross Margin i69.7%40.9%
Research & Development i72.03M1.40B
Operating Income (EBIT) i-13.08M8.11B
Operating Margin i-3.1%18.2%
EBITDA i13.35M11.86B
EBITDA Margin i3.1%26.6%
Pre-Tax Income i-21.14M7.31B
Pre-Tax Income % of Revenue i-4.9%16.4%
Income Tax i-116,000547.00M
Income Tax % of Revenue i0.0%1.2%
Net Income (Profit) i-21.02M6.72B
Profit Margin i-4.9%15.1%

Balance Sheet & Liquidity Metrics

MetricWGS (2025)TMO (2025)
Cash & Equivalents i105.00M9.85B
Total Current Assets i268.29M28.71B
Total Current Assets % of Revenue i62.8%64.4%
Total Current Liabilities i108.91M15.19B
Total Current Liabilities % of Revenue i25.5%34.1%
Long-Term Debt i104.22M35.85B
Long-Term Debt % of Revenue i24.4%80.5%
Total Shareholders Equity i308.18M53.54B
Retained Earnings i-1.37B59.16B
Retained Earnings % of Revenue i-321.3%132.8%
Property, Plant & Equipment i56.30M0

Cash Flow Statement Comparison

MetricWGS (2025)TMO (2025)
Operating Cash Flow i21.04M7.82B
Operating Cash Flow % of Revenue i4.9%17.5%
Capital Expenditures i-19.02M-1.48B
Free Cash Flow i14.26M6.29B
FCF Margin i3.3%14.1%
Debt Repayment i-3.66M-3.51B
Common Stock Repurchase iN/A-3.00B

Short Interest & Institutional Ownership Analysis

MetricWGSTMO
Shares Short i3.94M4.54M
Short Ratio i4.952.38
Short % of Float i26.48%1.22%
Shares Outstanding i29.25M371.62M
Float Shares i20.85M371.07M
% Held by Insiders i12.56%0.17%
% Held by Institutions i104.86%95.23%
% Held by Public i-17.42%4.60%

Dividend Analysis & Yield Comparison: Genedx Holdings Corp vs Thermo Fisher Scientific Inc.

MetricWGSTMO
Last 12-Month Dividend iN/A$1.76
Last 12-Month Dividend Yield iN/A0.38%
3-Year Avg Annual Dividend iN/A$1.60
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends iN/A$4.80
Ex-Dividend DateN/AMar 13, 2026